Mazdak Ganjalikhani Hakemi PhD (Isfahan University of Medical Sciences)

Dr. Mazdak Ganjalikhani Hakemi is an Associate Professor and Senior Researcher at Istanbul Medipol University in Istanbul, Turkey, having completed his PhD at Isfahan University of Medical Sciences. His research focuses on immunology and cell-based therapies, with particular emphasis on T helper cell subsets (Th17, Treg), innate lymphoid cells, and their roles in autoimmune diseases, immunodeficiencies, and inflammatory conditions such as asthma, multiple sclerosis, common variable immunodeficiency, and ankylosing spondylitis. He has also investigated mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapeutic approaches, contributing his most-cited work, "Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy" (2020), which has been cited 96 times. With over 20 indexed publications, Dr. Hakemi's work spans molecular mechanisms of immune regulation, cytokine signaling, microRNA modulation, and translational applications in cancer and immunological disorders.